The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including Ozempic and Wegovy, the drugs at the center of the weight-loss craze. The Biden administration said the drugs account for $41 billion in annual Medicare spending,
With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.
On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian Thompson, who headed the company's UnitedHealthcare unit. See: FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%.
A reader is trying to plan ahead to avoid the dreaded surcharges that can come out of your Social Security check.
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt. Shares of the
Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt
UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Medicare premiums and deductibles increased in 2025 from 2024 levels, with Part B premiums rising by about 6%. To get the most from your plan, it’s important to understand your out-of-pocket ...
If you have a question about IRMAA or recently got a letter from Social Security about it, let me know. You can write to [email protected]. Craig Cheney travels the country making ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...